Catalyst Wire Dossier Catalyst Wire Dossier

Raltegravir

raltegravir · Merck & Co.
Drug timelines are a Plus or Pro feature.

103 regulatory and trial events tracked for Raltegravir, covering 2008-11-18 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy [Phase 2]

See pricing